Australia markets closed
  • ALL ORDS

    7,107.10
    +56.10 (+0.80%)
     
  • AUD/USD

    0.7771
    +0.0021 (+0.28%)
     
  • ASX 200

    6,823.70
    +53.30 (+0.79%)
     
  • OIL

    52.86
    -0.45 (-0.84%)
     
  • GOLD

    1,869.70
    +3.20 (+0.17%)
     
  • BTC-AUD

    42,139.64
    -1,063.79 (-2.46%)
     
  • CMC Crypto 200

    650.35
    -50.26 (-7.17%)
     

Global Label-Free Detection Technology Market (2020 to 2030) - by Product Type, Technology, Application and End-user - ResearchAndMarkets.com

·2-min read

The "Label-Free Detection Technology Market Research Report: By Product Type, Technology, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The global label-free detection technology market is predicted to progress at a CAGR of 9.0% from 2020 to 2030. Furthermore, the market would attain a valuation of $3,097.4 million in 2030.

The key factors causing the boom of the market are the rising incidence of chronic diseases, soaring healthcare expenditure, and the growing public awareness about label-free detection technology because of the numerous initiatives being taken by private and public companies across the world.

The ongoing COVID-19 pandemic has massively increased the rates of mortality and morbidity among people all over the world. Moreover, the pandemic has made the healthcare sector of both developing and developed nations overburdened. In addition to this, the restrictions put in manufacturing activities and international and domestic trade, on account of the lockdowns imposed in several countries for mitigating the spread of the virus, has caused a considerably slow down of the global economy. However, the rapidly rising number of COVID-19 infected patients in many countries is pushing up the demand for label-free detection technology assays, which is, in turn, propelling the growth of the market.

Globally, the label-free detection technology market is currently exhibiting the highest growth in North America, on account of the large-scale utilization of the technology in the region for the screening of people diagnosed with chronic diseases. Besides the rising incidence of chronic diseases, the existence of major label-free detection technology providers in the region is also fueling the surge of the industry in the region.

Market Dynamics

Trends

  • Technological advancements

  • Approval and launch of new products

Drivers

  • Increasing strategic developments for drug discovery

  • Surging burden of chronic diseases

  • Increasing healthcare expenditure

  • Initiatives taken by public and private organizations to raise awareness about label-free detection technologies

  • Impact analysis of drivers on market forecast

Restraints

  • Cost-intensive nature of instruments

  • Impact analysis of restraints on market forecast

Opportunities

  • Extensive research to enhance sensitivity and throughput

Companies Mentioned

  • General Electric Company

  • Thermo Fisher Scientific Inc.

  • Danaher Corporation

  • F. Hoffmann-La Roche Ltd.

  • PerkinElmer Inc.

  • Hitachi Ltd.

  • Malvern Panalytical Ltd.

  • Sartorius Stedim Biotech S.A.

  • Waters Corporation

  • HORIBA Ltd.

  • Mettler-Toledo International Inc.

  • Agilent Technologies Inc.

  • Corning Incorporated

  • AMETEK Inc.

For more information about this report visit https://www.researchandmarkets.com/r/pnlgl0

View source version on businesswire.com: https://www.businesswire.com/news/home/20201124005755/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900